Effects of methysergide, bromocriptine and naloxone on prolactin, growth hormone and TSH release induced by d-Met2,Pro5-enkephalinamide in man

J. Földes, A. Váradi, A. Gara, C. Bános, P. Vargha, K. Török, J. I. Székely

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

d-Met2,Pro5-enkephalinamide (EA) 10 mg, given SC, induced a dramatic rise in serum prolactin (PRL) and growth hormone (GH) levels in healthy male volunteers. The TSH content was also moderately elevated. Naloxone 0.8 mg administered IV abolished these effects. Bromocriptine 2.5 mg given per os also antagonized EA-induced PRL and TSH release but potentiated the GH surge. Methysergide 2.0 mg administered orally partially reversed EA-elicited PRL release, further augmented GH liberation and did not modify TSH output. The data indicate that inhibition of the dopaminergic tone and/or activation of certain serotonergic mechanisms play an important role in the EA-induced release of PRL and TSH. However, primarily other neurotransmitters might mediate the GH liberation elicited by this opioid peptide.

Original languageEnglish
Pages (from-to)331-335
Number of pages5
JournalPsychopharmacology
Volume88
Issue number3
DOIs
Publication statusPublished - Mar 1986

Fingerprint

Methysergide
Bromocriptine
Naloxone
Prolactin
Growth Hormone
Opioid Peptides
Neurotransmitter Agents
Healthy Volunteers
Serum

Keywords

  • Bromocriptine
  • d-Met,Pro-enkephalina-mide
  • Dopaminergic agonists
  • Growth hormone
  • Methysergide
  • Opioid peptides
  • Prolactin
  • Serotonergic antagonists
  • TSH

ASJC Scopus subject areas

  • Pharmacology

Cite this

Effects of methysergide, bromocriptine and naloxone on prolactin, growth hormone and TSH release induced by d-Met2,Pro5-enkephalinamide in man. / Földes, J.; Váradi, A.; Gara, A.; Bános, C.; Vargha, P.; Török, K.; Székely, J. I.

In: Psychopharmacology, Vol. 88, No. 3, 03.1986, p. 331-335.

Research output: Contribution to journalArticle

@article{84f53c6ea19c4566a68e21d5980cafe9,
title = "Effects of methysergide, bromocriptine and naloxone on prolactin, growth hormone and TSH release induced by d-Met2,Pro5-enkephalinamide in man",
abstract = "d-Met2,Pro5-enkephalinamide (EA) 10 mg, given SC, induced a dramatic rise in serum prolactin (PRL) and growth hormone (GH) levels in healthy male volunteers. The TSH content was also moderately elevated. Naloxone 0.8 mg administered IV abolished these effects. Bromocriptine 2.5 mg given per os also antagonized EA-induced PRL and TSH release but potentiated the GH surge. Methysergide 2.0 mg administered orally partially reversed EA-elicited PRL release, further augmented GH liberation and did not modify TSH output. The data indicate that inhibition of the dopaminergic tone and/or activation of certain serotonergic mechanisms play an important role in the EA-induced release of PRL and TSH. However, primarily other neurotransmitters might mediate the GH liberation elicited by this opioid peptide.",
keywords = "Bromocriptine, d-Met,Pro-enkephalina-mide, Dopaminergic agonists, Growth hormone, Methysergide, Opioid peptides, Prolactin, Serotonergic antagonists, TSH",
author = "J. F{\"o}ldes and A. V{\'a}radi and A. Gara and C. B{\'a}nos and P. Vargha and K. T{\"o}r{\"o}k and Sz{\'e}kely, {J. I.}",
year = "1986",
month = "3",
doi = "10.1007/BF00180834",
language = "English",
volume = "88",
pages = "331--335",
journal = "Psychopharmacology",
issn = "0033-3158",
publisher = "Springer Verlag",
number = "3",

}

TY - JOUR

T1 - Effects of methysergide, bromocriptine and naloxone on prolactin, growth hormone and TSH release induced by d-Met2,Pro5-enkephalinamide in man

AU - Földes, J.

AU - Váradi, A.

AU - Gara, A.

AU - Bános, C.

AU - Vargha, P.

AU - Török, K.

AU - Székely, J. I.

PY - 1986/3

Y1 - 1986/3

N2 - d-Met2,Pro5-enkephalinamide (EA) 10 mg, given SC, induced a dramatic rise in serum prolactin (PRL) and growth hormone (GH) levels in healthy male volunteers. The TSH content was also moderately elevated. Naloxone 0.8 mg administered IV abolished these effects. Bromocriptine 2.5 mg given per os also antagonized EA-induced PRL and TSH release but potentiated the GH surge. Methysergide 2.0 mg administered orally partially reversed EA-elicited PRL release, further augmented GH liberation and did not modify TSH output. The data indicate that inhibition of the dopaminergic tone and/or activation of certain serotonergic mechanisms play an important role in the EA-induced release of PRL and TSH. However, primarily other neurotransmitters might mediate the GH liberation elicited by this opioid peptide.

AB - d-Met2,Pro5-enkephalinamide (EA) 10 mg, given SC, induced a dramatic rise in serum prolactin (PRL) and growth hormone (GH) levels in healthy male volunteers. The TSH content was also moderately elevated. Naloxone 0.8 mg administered IV abolished these effects. Bromocriptine 2.5 mg given per os also antagonized EA-induced PRL and TSH release but potentiated the GH surge. Methysergide 2.0 mg administered orally partially reversed EA-elicited PRL release, further augmented GH liberation and did not modify TSH output. The data indicate that inhibition of the dopaminergic tone and/or activation of certain serotonergic mechanisms play an important role in the EA-induced release of PRL and TSH. However, primarily other neurotransmitters might mediate the GH liberation elicited by this opioid peptide.

KW - Bromocriptine

KW - d-Met,Pro-enkephalina-mide

KW - Dopaminergic agonists

KW - Growth hormone

KW - Methysergide

KW - Opioid peptides

KW - Prolactin

KW - Serotonergic antagonists

KW - TSH

UR - http://www.scopus.com/inward/record.url?scp=0022590826&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022590826&partnerID=8YFLogxK

U2 - 10.1007/BF00180834

DO - 10.1007/BF00180834

M3 - Article

VL - 88

SP - 331

EP - 335

JO - Psychopharmacology

JF - Psychopharmacology

SN - 0033-3158

IS - 3

ER -